J0577 Inj, brixadi, 7 days or less
Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
- Medicare coverage: Carrier judgment
- Status: active (July 2026 file)
- MUE: max 1 units per day (practitioner), rationale: Prescribing Information